Skip to content

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here. Hide this message

Laboratory Medicine

Test Directory / Ferritin

Ferritin

Brown clotted serum, gel barrier

TestFerritin
Common AbbreviationsFER
ProfileHaematinics
Tube typeBrown clotted serum, gel barrier
Clinical IndicationFerritin plays a significant role in the absorption, storage, and release of iron. Ferritin is found in the serum in low concentrations and is directly proportional to the body's iron stores. Serum ferritin concentration, when analysed with other factors such as serum transferrin saturation and tissue iron stores, is valuable in the diagnosis of iron deficiency anaemia, anaemia of chronic infection, thalassaemia and haemachromatosis. Measurement of serum ferritin is particularly valuable in distinguishing iron deficiency anaemias caused by low iron stores from those resulting from inadequate iron utilization.
Specimen TypeBlood
Sample typeSerum
Minimum Volume0.5mL If requesting more than 10 tests please send an additional brown clotted serum sample.
Special PrecautionsNo special requirements
Stability48 hours at 20 - 25°C, 7 days at 2 - 8°C and 12 months at -20°C
Turnaround TimeInpatient: 24 hours Outpatient/ GP: 24 hours
LaboratoryYork and Scarborough
Reference IntervalMale: 30 - 400 µg/L (Quoted by the manufacturer) Females <60y: <15 µg/L consistent with iron deficiency, 15 - 30 µg/L may suggest depletion of iron stores, 30 - 150 µg/L Normal (Locally agreed based on manufacturer range) Females >60y: <15 µg/L consistent with iron deficiency, 15 - 30 µg/L may suggest depletion of iron stores (Locally agreed based on manufacturer range), 30 - 260 µg/L Normal (Derived in-house)
LimitationsAnalysis should not be performed on haemolysed, icteric or lipaemic samples. The assay is unaffected by biotin < 205 nmol/L or < 50 ng/mL. No interference was observed from rheumatoid factors up to a concentration of 1200 IU/mL. Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. In rare cases, interference due to extremely high titers of antibodies to analyte specific antibodies, streptavidin or ruthenium can occur. In vitro tests were performed on 16 commonly used pharmaceuticals. No interference with the assay was found.
Notes
York Hospital's car park.

Getting here

Chinese Poland

View all languages >

Maternity access at York Hospital - Saturday 22 February

On Saturday 22 February, 8am-6pm, there will be a temporary change of vehicle access to the maternity unit at York Hospital. Access via entrance 2 will be closed to allow essential works to be completed. 

If you are attending the maternity unit at York on this day, please drive in via the entrance for A&E (marked blue light priority).

The multi-storey car park will not be affected by this change, and any non-urgent visitors should continue to park in this area.